NASDAQ-listed Chinese high-end hospital operator Chindex International, Inc. says that it has entered into an amended merger agreement with TPG Capital, Shanghai Fosun Pharmaceutical and the company's CEO Roberta Lipson to take the company private for $24 per share in cash, according to a company announcement. The amended agreement removes one more uncertainty for the […]

Visit for more great China Money Podcast audio and video Internet episodes covering important investment news and financial events in China, as well as daily news updates on important China business news happenings. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.

Visit the original source and full text: China Money Network